The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is one of the most exacting regulatory authorities in the world. Their specialist inspectors are highly trained to identify problems, deviations and discrepancies in clinical research. One of the best ways to learn about the inspectorate and its areas of focus is to consider the inspection findings which they have made. This web seminar will bring learners up-to-date on the current findings of the MHRA, which areas cause the regulator the most concern, and how they interpret the regulations and guidance to which they hold researchers accountable.
- Describe the remit of the MHRA
- Explain the main areas of concern to the MHRA
- Become aware of the most common and most significant findings being written by the MHRA
- Understand where the MHRA applies enforcement discretion
- Clinical Researchers from Industry, Academia and CROs
- Quality Assurance Professionals from Industry, Academia and CROs
- Personnel with an interest in the quality of clinical research
The course will be led by one of the following instructors:
Paul Strickland, B.Sc., FRQA, DipRQA
Click here for complete trainer biographies
Hold this course at your company! For more information, contact Naila Ganatra at +1 215.413.2471.